Literature DB >> 8805137

Supratentorial cavernous angiomas and epileptic seizures: preoperative course and postoperative outcome.

M Casazza1, G Broggi, A Franzini, G Avanzini, R Spreafico, M Bracchi, M C Valentini.   

Abstract

OBJECTIVE: Patients operated on for supratentorial cavernous angiomas were studied to define the incidence and the course of seizures in their clinical history. Electroclinical and neuroradiological data were correlated with the location of cavernomas. The impact of lesionectomy on the outcome of seizures was evaluated.
METHODS: Preoperative clinical data on the history of the seizures, semeiology, incidence, severity, and response to antiepileptic drugs were analyzed. The location of the cavernomas, revealed by magnetic resonance imaging, was correlated with electroencephalographic and clinical data. Postoperative clinical and neuroradiological data were evaluated, with particular consideration to the outcome of the seizures, antiepileptic drug withdrawal, and the completeness of the lesion excision.
RESULTS: A higher incidence of severe epilepsy was observed in the patients with mesiotemporal and cortical angiomas. In most of the patients (78.7%), a good concordance between the site of the lesion and the electroclinical data was found. The complete removal of the lesion led to a favorable outcome, with discontinuation of antiepileptic drugs achieved in one-quarter of the patients.
CONCLUSION: A high percentage of patients with cortical cavernomas had epileptic seizures. They often presented with chronic intractable epilepsy (44.7% in our series). In cases of good concordance between the electroclinical data and the location of the angioma, complete lesionectomy led to the disappearance of seizures. Removal of the hemosiderin ring did not correlate with better outcome. Preoperative ictal scalp recordings to assess the topographic relationship between the cavernoma and the epileptic seizures could improve outcome, which suggests different surgical strategies (lesionectomy versus enlarged resection) in patients without a clear-cut concordance between the site of the lesion and the ictal semeiology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8805137     DOI: 10.1097/00006123-199607000-00007

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  17 in total

Review 1.  Management of hemorrhage from cavernous malformations.

Authors:  Sachin Batra; Karen Rigamonti; Daniele Rigamonti
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

Review 2.  Cavernous malformations: natural history, diagnosis and treatment.

Authors:  Sachin Batra; Doris Lin; Pablo F Recinos; Jun Zhang; Daniele Rigamonti
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

Review 3.  Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series.

Authors:  N F Moran; D R Fish; N Kitchen; S Shorvon; B E Kendall; J M Stevens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

4.  Epilepsy Lesion Localization is not Predicted by Developmental Venous Anomaly Location or its FDG-PET Metabolic Activity.

Authors:  Jillian W Lazor; Joel M Stein; James Eric Schmitt; Kathryn A Davis; Seyed Ali Nabavizadeh
Journal:  J Neuroimaging       Date:  2020-05-08       Impact factor: 2.486

5.  Patient-assessed satisfaction and outcome after microsurgical resection of cavernomas causing epilepsy.

Authors:  Jamie J Van Gompel; W Richard Marsh; Fredric B Meyer; Gregory A Worrell
Journal:  Neurosurg Focus       Date:  2010-09       Impact factor: 4.047

6.  Electrocorticography-guided resection of temporal cavernoma: is electrocorticography warranted and does it alter the surgical approach?

Authors:  Jamie J Van Gompel; Jesus Rubio; Gregory D Cascino; Gregory A Worrell; Fredric B Meyer
Journal:  J Neurosurg       Date:  2009-06       Impact factor: 5.115

7.  Seizure risk from cavernous or arteriovenous malformations: prospective population-based study.

Authors:  C B Josephson; J-P Leach; R Duncan; R C Roberts; C E Counsell; R Al-Shahi Salman
Journal:  Neurology       Date:  2011-05-03       Impact factor: 9.910

8.  Surgical treatment for refractory epilepsy: review of patient evaluation and surgical options.

Authors:  Kristen M Kelly; Steve S Chung
Journal:  Epilepsy Res Treat       Date:  2011-06-05

9.  Surgical management of cavernous malformations presenting with drug-resistant epilepsy.

Authors:  Mario Arturo Alonso-Vanegas; José M Cisneros-Franco; Taisuke Otsuki
Journal:  Front Neurol       Date:  2012-01-03       Impact factor: 4.003

10.  Seizure Incidence Rates in Children and Adults With Familial Cerebral Cavernous Malformations.

Authors:  Christine K Fox; Jeffrey Nelson; Charles E McCulloch; Shantel Weinsheimer; Ludmila Pawlikowska; Blaine Hart; Marc Mabray; Atif Zafar; Leslie Morrison; Joseph M Zabramski; Amy Akers; Helen Kim
Journal:  Neurology       Date:  2021-08-13       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.